No Alteration of Voriconazole Concentration by Plasmapheresis in a Critically Ill Patient
Overview
Overview
Authors
Affiliations
Affiliations
Soon will be listed here.
Citing Articles
Effect of therapeutic plasma exchange on antimicrobials in critically ill patients.
Balaban U, Kara E, Kaya E, Ozcebe O, Akova M, Topeli A Crit Care. 2024; 28(1):280.
PMID: 39198857 PMC: 11350938. DOI: 10.1186/s13054-024-05077-w.
Drug Dosing in Patients Undergoing Therapeutic Plasma Exchange.
Mahmoud S, Buhler J, Chu E, Chen S, Human T Neurocrit Care. 2020; 34(1):301-311.
PMID: 32445106 DOI: 10.1007/s12028-020-00989-1.
References
1.
Kintzel P, Eastlund T, Calis K
. Extracorporeal removal of antimicrobials during plasmapheresis. J Clin Apher. 2003; 18(4):194-205.
DOI: 10.1002/jca.10074.
View
2.
Theuretzbacher U, Ihle F, Derendorf H
. Pharmacokinetic/pharmacodynamic profile of voriconazole. Clin Pharmacokinet. 2006; 45(7):649-63.
DOI: 10.2165/00003088-200645070-00002.
View
3.
Ibrahim R, Liu C, Cronin S, Murphy B, Cha R, Swerdlow P
. Drug removal by plasmapheresis: an evidence-based review. Pharmacotherapy. 2007; 27(11):1529-49.
DOI: 10.1592/phco.27.11.1529.
View
4.
Pascual A, Csajka C, Buclin T, Bolay S, Bille J, Calandra T
. Challenging recommended oral and intravenous voriconazole doses for improved efficacy and safety: population pharmacokinetics-based analysis of adult patients with invasive fungal infections. Clin Infect Dis. 2012; 55(3):381-90.
DOI: 10.1093/cid/cis437.
View
5.
Spriet I, Bruggemann R, Annaert P, Meersseman P, Van Wijngaerden E, Lagrou K
. Pharmacokinetic profile of voriconazole in a critically ill patient on therapeutic plasma exchange. Ther Drug Monit. 2013; 35(1):141-3.
DOI: 10.1097/FTD.0b013e31827d76b0.
View